Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBarr (A.G.) Regulatory News (BAG)

Share Price Information for Barr (A.G.) (BAG)

Share Price is delayed by 15 minutes
Get Live Data
604.00    -9.00 (-1.47%)
Bid:
603.00
Ask:
605.00
Spread: 2.00 (0.332%)
Market Cap: £670.29m
BAG Live PriceLast checked at - London Stock Exchange

Intraday Barr (A.G.) Share Chart

Merger Update

14 Feb 2013 10:22

RNS Number : 8895X
Barr(A.G.) PLC
14 February 2013
 



NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

For Immediate Release

14 February 2013

A.G. BARR p.l.c. ("A.G. Barr") and Britvic plc ("Britvic")

All-share merger update: decision to seek Competition Commission clearance

The Boards of A.G. Barr and Britvic refer to their joint announcement noting the decision by the Office of Fair Trading (the "OFT") to refer the proposed merger of A.G. Barr and Britvic (the "Merger") to the Competition Commission due to concerns that the Merger could reduce competition between certain brands of A.G. Barr and Britvic.

 

A.G. Barr and Britvic believe that the merger will not result in a substantial lessening of competition and that they will be able to demonstrate this to the Competition Commission. The Boards of A.G. Barr and Britvic therefore intend to work together with the Competition Commission during its investigation with a view to seeking clearance of the proposed merger. The Competition Commission's investigation is expected to take approximately six months. If clearance is received from the Competition Commission on terms satisfactory to both A.G. Barr and Britvic, the Boards of A.G. Barr and Britvic will each reconsider, at that time, the terms of a possible merger between A.G. Barr and Britvic. There can be no certainty or assurance that, following such clearance, any such merger would be forthcoming or that any offer will be made by either A.G. Barr or Britvic.

 

A.G. Barr and Britvic consider there to be compelling rationale for clearance. The view of the two Boards on the benefits of the transaction is unchanged and they continue to believe that it is in the interests of the two shareholder groups. A.G. Barr and Britvic will continue to work closely with the authorities to expedite clearance.

 

Capitalised terms used but not defined in this announcement have the same meanings as set out in the Scheme Document dated 5 December 2012.

Enquiries

A.G. BARR p.l.c.

Roger White

Alex Short +44 (0) 1236 852 400

Rothschild (financial adviser to A.G. Barr)

Akeel Sachak

Stuart Vincent

Jessica Dale +44 (0) 207 280 5000

Investec Bank plc (broker to A.G. Barr)

Keith Anderson

David Anderson

Henry Reast +44 (0) 207 597 5970

College Hill (PR adviser to A.G. Barr)

Justine Warren

Matthew Smallwood +44 (0) 207 457 2020

Britvic plc

Gerald Corbett

John Gibney

Rupen Shah

Steve Nightingale +44 (0) 1442 284330

Citigroup Global Markets Limited

(joint financial adviser and joint broker to Britvic)

David Wormsley

Jan Skarbek

Andrew Seaton +44 (0) 207 986 4000

Nomura International plc

(joint financial adviser and joint broker to Britvic)

Nicholas Marren

Ed Matthews +44 (0) 207 521 2000

Brunswick (PR adviser to Britvic)

Mike Smith

Nick Cosgrove +44 (0) 207 404 5959

 

Rothschild, which is authorised and regulated in the United Kingdom by the FSA, is acting exclusively for A.G. Barr and for no-one else in connection with the matters set out in this announcement and will not be responsible to anyone other than A.G. Barr for providing the protections afforded to its clients or for providing advice in connection with the matters set out in this announcement.

Investec Bank plc, which is authorised and regulated in the United Kingdom by the FSA, is acting as corporate broker to A.G. Barr and for no-one else in connection with the matters set out in this announcement and will not be responsible to anyone other than A.G. Barr for providing the protections afforded to its clients or for providing advice in connection with the matters set out in this announcement.

Citigroup Global Markets Limited, which is authorised and regulated in the United Kingdom by the FSA, is acting exclusively for Britvic and for no-one else in connection with the matters set out in this announcement and will not be responsible to anyone other than Britvic for providing the protections afforded to its clients or for providing advice in connection with the matters set out in this announcement.

Nomura International plc, which conducts its UK investment banking business as Nomura, is authorised and regulated in the United Kingdom by the FSA and is acting as joint broker and joint financial adviser to Britvic and for no-one else in connection with the matters set out in this announcement. Nomura will not be responsible to anyone other than Britvic for providing the protection afforded to its clients or for providing advice in connection with the matters set out in this announcement.

Publication on website

A copy of this announcement will be made available, free of charge, subject to certain restrictions relating to persons resident in restricted jurisdictions, on Britvic's and A.G. Barr's websites at http://ir.britvic.comand www.agbarr.co.ukrespectively by no later than noon (London time) on the day following the date of this announcement. For the avoidance of doubt, the contents of those websites are not incorporated into and do not form part of this announcement.

You may request a hard copy of this announcement by contacting the Company Secretary of Britvic at company.secretariat@britvic.co.uk (or on +44(0)1442 284411) or by writing to Britvic plc, Breakspear Park, Breakspear Way, Hemel Hempstead, HP2 4TZ, or by contacting the Company Secretary of A.G. Barr at companysecretarialdepartment@agbarr.co.uk (or on +44(0)1236 852400) or by writing to A.G. BARR p.l.c., Westfield House, 4 Mollins Road, Cumbernauld, G68 9HD. You may also request that all future documents, announcements and information to be sent to you in relation to the Merger should be in hard copy form.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MERZMGMZGDMGFZM
Date   Source Headline
2nd Aug 20177:00 amRNSTrading Update
28th Jul 20175:00 pmRNSClose period repurchase programme
26th Jul 20177:00 amRNSTransaction in Own Shares
25th Jul 20171:45 pmRNSDirector/PDMR Shareholding
25th Jul 20177:00 amRNSTransaction in Own Shares
24th Jul 20171:37 pmRNSDirector/PDMR Shareholding
17th Jul 20178:09 amRNSTransaction in Own Shares
14th Jul 20177:43 amRNSTransaction in Own Shares
13th Jul 201710:07 amRNSNotice of Trading Update
10th Jul 20172:21 pmRNSDirector/PDMR Shareholding
28th Jun 20177:13 amRNSTransaction in Own Shares
27th Jun 201712:14 pmRNSTransaction in Own Shares
14th Jun 20173:25 pmRNSDirector/PDMR Shareholding
14th Jun 20177:00 amRNSTransaction in Own Shares
13th Jun 20177:14 amRNSTransaction in Own Shares
12th Jun 20171:33 pmRNSDirector/PDMR Shareholding
12th Jun 20171:32 pmRNSDirector/PDMR Shareholding
12th Jun 20171:30 pmRNSDirector/PDMR Shareholding
12th Jun 20171:28 pmRNSDirector/PDMR Shareholding
8th Jun 20172:02 pmRNSDirector/PDMR Shareholding
6th Jun 20174:04 pmRNSDirector/PDMR Shareholding
31st May 201712:38 pmRNSAGM Statement
18th May 20177:00 amRNSTransaction in Own Shares
9th May 20171:20 pmRNSDirector/PDMR Shareholding
3rd May 20179:43 amRNSDirector/PDMR Shareholding
27th Apr 20174:08 pmRNSAnnual Report and Accounts and Notice of AGM
26th Apr 201712:17 pmRNSDirector/PDMR Shareholding
10th Apr 201712:12 pmRNSDirector/PDMR Shareholding
3rd Apr 20173:47 pmRNSDirector/PDMR Shareholding
28th Mar 20177:00 amRNSFinal Results
8th Mar 20172:49 pmRNSDirector/PDMR Shareholding
1st Mar 20177:00 amRNSFurther reduction of sugar across portfolio
8th Feb 20171:34 pmRNSDirector/PDMR Shareholding
1st Feb 20177:00 amRNSTrading Update
12th Jan 20177:00 amRNSNotice of Trading Update
10th Jan 20172:10 pmRNSDirector/PDMR Shareholding
9th Jan 20174:35 pmRNSPrice Monitoring Extension
9th Jan 20172:56 pmRNSDirector Declaration
13th Dec 20167:00 amRNSAnalyst Site Visit
8th Dec 201612:42 pmRNSDirector/PDMR Shareholding
14th Nov 201611:23 amRNSHolding(s) in Company
10th Nov 20162:59 pmRNSHolding(s) in Company
8th Nov 201612:42 pmRNSDirector/PDMR Shareholding
25th Oct 201611:33 amRNSDirector/PDMR Shareholding
25th Oct 201611:20 amRNSDirector/PDMR Shareholding
25th Oct 201611:19 amRNSDirector/PDMR Shareholding
25th Oct 201611:13 amRNSDirector/PDMR Shareholding
10th Oct 20161:27 pmRNSDirector/PDMR Shareholding
28th Sep 20162:13 pmRNSCorrection: Interim Results
27th Sep 20167:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.